Share:
Share this content in WeChat
X
• Review •
Advances in the clinical applications of multimodal quantitative MRI in sarcopenia
YU Jun  NIU Jinliang 

DOI:10.12015/issn.1674-8034.2026.11.027.


[Abstract] Sarcopenia is a progressive and generalized skeletal muscle disorder characterized by loss of skeletal muscle mass, reduced muscle strength, and impaired physical performance, and it is associated with increased risks of frailty, falls, fractures, perioperative complications, and mortality. As clinical assessment has shifted from muscle quantity alone toward integrated evaluation of muscle quality, strength, physical performance, and clinical outcomes, multimodal quantitative magnetic resonance imaging (MRI), which can noninvasively characterize muscle reserve, fat infiltration, tissue water content, microstructure, and metabolism, has gained increasing importance for phenotyping, treatment monitoring, and risk stratification. However, previous reviews have largely focused on MRI sequence principles or isolated quantitative parameters, with insufficient synthesis of how individual biomarkers address specific clinical questions, their evidence boundaries, and barriers to translation. This review aims to provide new perspectives for imaging research and refined clinical assessment of sarcopenia. We summarize the advantages of MRI assessment in sarcopenia, major quantitative MRI techniques and biomarkers, and their applications in diagnostic phenotyping, intervention monitoring, functional associations and exploratory risk stratification, comorbidity assessment, potential perioperative risk stratification, radiomics, and artificial intelligence. We also discuss current challenges in acquisition protocols, segmentation standards, reference thresholds, cross-platform consistency, and validation against clinical outcomes.Current evidence suggests that muscle volume, proton density fat fraction, and intermuscular adipose tissue have the greatest translational potential, whereas T2 relaxation time mapping, diffusion-weighted imaging, diffusion tensor imaging, and magnetic resonance spectroscopy provide complementary information on edema/inflammation, fiber microstructure, and energy metabolism but still require further standardization and longitudinal validation. Evidence linking MRI biomarkers to prospective hard clinical outcomes remains limited .We propose that future studies should establish stratified reference ranges for Chinese and Asian populations, harmonize multicenter acquisition, segmentation, and quality-control procedures, and integrate multiparametric MRI with muscle strength, physical performance, nutritional and inflammatory markers, and artificial-intelligence-based automated analysis. Prospective multicenter longitudinal studies should further determine the incremental value of these biomarkers for falls, hospitalization, perioperative complications, and mortality and clarify whether imaging changes translate into functional and clinical benefits, thereby promoting quantitative MRI from a research tool to an imaging biomarker that supports individualized clinical decision-making.
[Keywords] sarcopenia;quantitative magnetic resonance imaging;skeletal muscle;muscle quality;proton density fat fraction;sarcopenic obesity;perioperative risk;artificial intelligence

YU Jun1   NIU Jinliang2*  

1 College of Medical Imaging, Shanxi Medical University, Taiyuan 030000, China

2 Department of Imaging, The Second Hospital of Shanxi Medical University, Taiyuan 030000, China

Corresponding author: NIU J L, E-mail: sxlscjy@163.com

Conflicts of interest   None.

Received  2026-04-29
Accepted  2026-10-21
DOI: 10.12015/issn.1674-8034.2026.11.027
DOI:10.12015/issn.1674-8034.2026.11.027.

[1]
CHEN L K, WOO J, ASSANTACHAI P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. DOI: 10.1016/j.jamda.2019.12.012.
[2]
KIRK B, CAWTHON P M, ARAI H, et al. The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS)[J/OL]. Age Ageing, 2024, 53(3): afae052 [2026-09-11]. https://pmc.ncbi.nlm.nih.gov/articles/PMC10960072/. DOI: 10.1093/ageing/afae052.
[3]
The Geriatrics Branch of the Chinese Medical Association, The National Clinical Research Center for Geriatric Disorders (Xiangya Hospital). Guideline for diagnosis and treatment of sarcopenia in China (2024 edition)[J]. Natl Med J China, 2025, 105(3): 181-203. DOI: 10.3760/cma.j.cn112137-20240724-01701.
[4]
CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1): 16-31. DOI: 10.1093/ageing/afy169.
[5]
CODARI M, ZANARDO M, DI SABATO M E, et al. MRI-derived biomarkers related to sarcopenia: a systematic review[J]. J Magn Reson Imaging, 2020, 51(4): 1117-1127. DOI: 10.1002/jmri.26931.
[6]
ENGELKE K, CHAUDRY O, GAST L, et al. Magnetic resonance imaging techniques for the quantitative analysis of skeletal muscle: State of the art[J]. J Orthop Translat, 2023, 42: 57-72. DOI: 10.1016/j.jot.2023.07.005.
[7]
HOOIJMANS M T, SCHLAFFKE L, BOLSTERLEE B, et al. Compositional and functional MRI of skeletal muscle: a review[J]. J Magn Reson Imaging, 2024, 60(3): 860-877. DOI: 10.1002/jmri.29091.
[8]
LINGE J, PETERSSON M, FORSGREN M F, et al. Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study[J]. J Cachexia Sarcopenia Muscle, 2021, 12(6): 1513-1526. DOI: 10.1002/jcsm.12834.
[9]
TAGLIAFICO A S, BIGNOTTI B, TORRI L, et al. Sarcopenia: how to measure, when and why[J]. Radiol Med, 2022, 127(3): 228-237. DOI: 10.1007/s11547-022-01450-3.
[10]
FARON A, SPRINKART A M, KUETTING D L R, et al. Body composition analysis using CT and MRI: intra-individual intermodal comparison of muscle mass and myosteatosis[J/OL]. Sci Rep, 2020, 10(1): 11765 [2026-09-11]. https://www.nature.com/articles/s41598-020-68797-3. DOI: 10.1038/s41598-020-68797-3.
[11]
THANAJ M, BASTY N, WHITCHER B, et al. Precision MRI phenotyping of muscle volume and quality at a population scale[J/OL]. Front Physiol, 2024, 15: 1288657 [2026-09-11]. https://www.frontiersin.org/articles/10.3389/fphys.2024.1288657. DOI: 10.3389/fphys.2024.1288657.
[12]
GARCIA-DIEZ A I, PORTA-VILARO M, ISERN-KEBSCHULL J, et al. Myosteatosis: diagnostic significance and assessment by imaging approaches[J]. Quant Imaging Med Surg, 2024, 14(11): 7937-7957. DOI: 10.21037/qims-24-365.
[13]
CHIANCA V, ALBANO D, MESSINA C, et al. Sarcopenia: imaging assessment and clinical application[J]. Abdom Radiol (NY), 2022, 47(9): 3205-3216. DOI: 10.1007/s00261-021-03294-3.
[14]
ZHANG X R, ZHANG X D. Research progress in quantitative assessment by multimodal MRI in skeletal muscle[J]. Int J Med Radiol, 2024, 47(6): 725-729, 735. DOI: 10.19300/j.2024.Z21361.
[15]
SINHA U, SINHA S. Magnetic resonance imaging biomarkers of muscle[J]. Tomography, 2024, 10(9): 1411-1438. DOI: 10.3390/tomography10090106.
[16]
MOHAJER B, DOLATSHAHI M, MORADI K, et al. Role of thigh muscle changes in knee osteoarthritis outcomes: osteoarthritis initiative data[J]. Radiology, 2022, 305(1): 169-178. DOI: 10.1148/radiol.212771.
[17]
JEON I, KIM S W, YU D. Paraspinal muscle fatty degeneration as a predictor of progressive vertebral collapse in osteoporotic vertebral compression fractures[J]. Spine J, 2022, 22(2): 313-320. DOI: 10.1016/j.spinee.2021.07.020.
[18]
SUZUKI N, EGUCHI Y, IWATA S, et al. Evaluation of trunk muscles in lumbar degenerative disease using magnetic resonance imaging T2 mapping: Association with computed tomography parameters and body composition[J]. J Orthop Sci, 2026, 31(3): 513-520. DOI: 10.1016/j.jos.2025.09.013.
[19]
HUANG Y L, WANG L, ZENG X M, et al. Association of paraspinal muscle CSA and PDFF measurements with lumbar intervertebral disk degeneration in patients with chronic low back pain[J/OL]. Front Endocrinol, 2022, 13: 792819 [2026-09-11]. https://www.frontiersin.org/articles/10.3389/fendo.2022.792819. DOI: 10.3389/fendo.2022.792819.
[20]
ECK B L, GAJ S, LARTEY R, et al. Reproducibility of proton density fat fraction assessment of thigh muscle in a multi-site, multi-vendor cohort study at 10 years after anterior cruciate ligament reconstruction[J]. Quant Imaging Med Surg, 2024, 14(12): 8099-8118. DOI: 10.21037/qims-24-287.
[21]
SCHLAEGER S, SOLLMANN N, ZOFFL A, et al. Quantitative muscle MRI in patients with neuromuscular diseases-association of muscle proton density fat fraction with semi-quantitative grading of fatty infiltration and muscle strength at the thigh region[J/OL]. Diagnostics (Basel), 2021, 11(6): 1056 [2026-09-11]. https://www.mdpi.com/2075-4418/11/6/1056. DOI: 10.3390/diagnostics11061056.
[22]
ZHANG W S, FU C, YAN D, et al. Quantification of volumetric thigh and paravertebral muscle fat content: comparison of quantitative Dixon (Q-Dixon) magnetic resonance imaging (MRI) with high-speed T2-corrected multiecho MR spectroscopy[J]. Quant Imaging Med Surg, 2024, 14(7): 4490-4505. DOI: 10.21037/qims-24-127.
[23]
FARROW M, BIGLANDS J, TANNER S F, et al. The effect of ageing on skeletal muscle as assessed by quantitative MR imaging: an association with frailty and muscle strength[J]. Aging Clin Exp Res, 2021, 33(2): 291-301. DOI: 10.1007/s40520-020-01530-2.
[24]
BARBIERI M, HOOIJMANS M T, MOULIN K, et al. A deep learning approach for fast muscle water T2 mapping with subject specific fat T2 calibration from multi-spin-echo acquisitions[J/OL]. Sci Rep, 2024, 14(1): 8253 [2026-09-11]. https://pubmed.ncbi.nlm.nih.gov/38589478/. DOI: 10.1038/s41598-024-58812-2.
[25]
FORSTING J, ROHM M, FROELING M, et al. Quantitative muscle MRI captures early muscle degeneration in calpainopathy[J/OL]. Sci Rep, 2022, 12: 19676 [2026-09-11]. https://www.nature.com/articles/s41598-022-23972-6. DOI: 10.1038/s41598-022-23972-6.
[26]
ASSI A, RAMADAN B, KARAM M, et al. Muscle fat infiltration: a narrative review of the magnetic resonance (MR)-based evaluation methods and their clinical applications[J]. Quant Imaging Med Surg, 2024, 14(12): 9563-9588. DOI: 10.21037/qims-24-177.
[27]
GHASEMIKARAM M, CHAUDRY O, NAGEL A M, et al. Effects of 16 months of high intensity resistance training on thigh muscle fat infiltration in elderly men with osteosarcopenia[J]. Geroscience, 2021, 43(2): 607-617. DOI: 10.1007/s11357-020-00316-8.
[28]
OTSUKA Y, YAMADA Y, MAEDA A, et al. Effects of resistance training intensity on muscle quantity/quality in middle-aged and older people: a randomized controlled trial[J]. J Cachexia Sarcopenia Muscle, 2022, 13(2): 894-908. DOI: 10.1002/jcsm.12941.
[29]
NEAL M A, BOLANO-DIAZ C F, RICHARDSON M, et al. Rapid quantitative assessment of muscle sodium dynamics after exercise using 23Na-MRI in dysferlinopathy and healthy controls[J/OL]. J Cachexia Sarcopenia Muscle, 2025, 16(1): e13709 [2026-09-11]. https://onlinelibrary.wiley.com/doi/10.1002/jcsm.13709. DOI: 10.1002/jcsm.13709.
[30]
GERHALTER T, MARTY B, GAST L V, et al. Longitudinal follow-up of patients with Duchenne muscular dystrophy using quantitative 23Na and 1H MRI[J/OL]. J Cachexia Sarcopenia Muscle, 2025, 16(2): e13812 [2026-09-11]. https://onlinelibrary.wiley.com/doi/10.1002/jcsm.13812. DOI: 10.1002/jcsm.13812.
[31]
NAËGEL A, VIALLON M, RATINEY H, et al. Impact of long-term fasting on skeletal muscle: structure, energy metabolism and function using 31P/1H MRS and MRI[J/OL]. J Cachexia Sarcopenia Muscle, 2025, 16(2): e13773 [2026-09-11]. https://onlinelibrary.wiley.com/doi/10.1002/jcsm.13773. DOI: 10.1002/jcsm.13773.
[32]
DE WEL B, HUYSMANS L, PEETERS R, et al. Test-retest reliability and follow-up of muscle magnetic resonance elastography in adults with and without muscle diseases[J]. J Cachexia Sarcopenia Muscle, 2024, 15(5): 1761-1771. DOI: 10.1002/jcsm.13528.
[33]
MARKEWITZ N, WU C, VANDSBURGER M, et al. Multiparametric quantitative magnetic resonance imaging of skeletal muscle in CKD[J]. Am J Physiol Renal Physiol, 2025, 329(1): F99-F111. DOI: 10.1152/ajprenal.00254.2024.
[34]
WANG L, LU S, FENG J H, et al. Muscle imaging assessments in sarcopenia: a statement from China national center for orthopedics (NCO) and the east meets west action group of the European calcified tissue society (ECTS)[J/OL]. Calcif Tissue Int, 2025, 116(1): 144 [2026-09-11]. https://link.springer.com/article/10.1007/s00223-025-01447-w. DOI: 10.1007/s00223-025-01447-w.
[35]
ANG S W, LIEW J, DHARMARATNAM V M, et al. Diagnostic performance of various radiological modalities in the detection of sarcopenia within Asian populations: a systematic review[J]. Ann Coloproctol, 2025, 41(1): 27-39. DOI: 10.3393/ac.2024.00080.0011.
[36]
DONINI L M, BUSETTO L, BISCHOFF S C, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement[J]. Obes Facts, 2022, 15(3): 321-335. DOI: 10.1159/000521241.
[37]
SHIIBA T, MORI S, SHIMOZONO T, et al. Assessment of age-related differences in lower leg muscles quality using radiomic features of magnetic resonance images[J]. J Imaging Inform Med, 2025, 38(2): 1040-1050. DOI: 10.1007/s10278-024-01268-7.
[38]
LU Y Y, YIN L, LIU C, et al. Quantitative MRI findings and their relationship to muscle histopathology and ambulatory clinical function in Duchenne muscular dystrophy[J/OL]. J Cachexia Sarcopenia Muscle, 2026, 17(1): e70205 [2026-09-11]. https://onlinelibrary.wiley.com/doi/10.1002/jcsm.70205. DOI: 10.1002/jcsm.70205.
[39]
EMANUELSSON E B, BERRY D B, REITZNER S M, et al. MRI characterization of skeletal muscle size and fatty infiltration in long-term trained and untrained individuals[J/OL]. Physiol Rep, 2022, 10(14): e15398 [2026-09-11]. https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.15398. DOI: 10.14814/phy2.15398.
[40]
LAURENT D, RIEK J, SINCLAIR C D J, et al. Longitudinal changes in MRI muscle morphometry and composition in people with inclusion body myositis[J/OL]. Neurology, 2022, 99(9): e865-e876 [2026-09-11]. https://pubmed.ncbi.nlm.nih.gov/36038279/. DOI: 10.1212/WNL.0000000000200776.
[41]
MAZZOLI V, VAINBERG Y, HALL M E, et al. Improved strength prediction combining MRI biomarkers of muscle quantity and quality[J/OL]. NMR Biomed, 2025, 38(9): e70112 [2026-09-11]. https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/nbm.70112. DOI: 10.1002/nbm.70112.
[42]
WANG L, LIU Y D, LI K, et al. Age and BMI have different effects on subcutaneous, visceral, liver, bone marrow, and muscle adiposity, as measured by CT and MRI[J]. Obesity (Silver Spring), 2024, 32(7): 1339-1348. DOI: 10.1002/oby.24040.
[43]
ZUO H Y, BI Q, LIU X L, et al. The value of unsupervised machine learning algorithms based on CT and MRI for predicting sarcopenia[J/OL]. Front Public Health, 2025, 13: 1649400 [2026-09-11]. https://www.frontiersin.org/articles/10.3389/fpubh.2025.1649400. DOI: 10.3389/fpubh.2025.1649400.
[44]
ROZYNEK M, KUCYBAŁA I, URBANIK A, et al. Use of artificial intelligence in the imaging of sarcopenia: a narrative review of current status and perspectives[J/OL]. Nutrition, 2021, 89: 111227 [2026-09-11]. https://doi.org/10.1016/j.nut.2021.111227. DOI: 10.1016/j.nut.2021.111227.
[45]
DING J, CAO P, CHANG H C, et al. Deep learning-based thigh muscle segmentation for reproducible fat fraction quantification using fat–water decomposition MRI[J/OL]. Insights Imaging, 2020, 11(1): 128 [2026-09-11]. https://insightsimaging.springeropen.com/articles/10.1186/s13244-020-00946-8. DOI: 10.1186/s13244-020-00946-8.
[46]
GAJ S, ECK B L, XIE D X, et al. Deep learning-based automatic pipeline for quantitative assessment of thigh muscle morphology and fatty infiltration[J]. Magn Reson Med, 2023, 89(6): 2441-2455. DOI: 10.1002/mrm.29599.
[47]
AKELLA V, BAGHERINASAB R, LEE H, et al. Automated body composition analysis using DAFS express on 2D MRI slices at L3 vertebral level[J]. J Imaging Inform Med, 2026, 39(1): 548-556. DOI: 10.1007/s10278-025-01544-0.
[48]
VERDU-DIAZ J, BOLANO-DÍAZ C, GONZALEZ-CHAMORRO A, et al. Myo-guide: a machine learning-based web application for neuromuscular disease diagnosis with MRI[J/OL]. J Cachexia Sarcopenia Muscle, 2025, 16(3): e13815 [2026-09-11]. https://onlinelibrary.wiley.com/doi/10.1002/jcsm.13815. DOI: 10.1002/jcsm.13815.

PREV Application and advances of magnetic resonance-guided adaptive radiotherapy in uterine malignancies
NEXT High-field and ultra-high-field MRI of the musculoskeletal system: advances and challenges in transitioning from structural visualization to microstructure and composition quantification
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn